Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2015-11-05 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
关于子公司部分资产被冻结、查封的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the freezing and seizure of certain assets of the company's subsidiaries due to a legal dispute. It details the affected bank accounts and properties, the company's response, and the impact on operations. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The content is a regulatory announcement about a legal and operational matter, fitting best under a general regulatory filing rather than a specific report type.
2015-11-05 Chinese
关于公司及子公司部分资产被冻结、查封的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. regarding the freezing and seizure of some of the company's and its subsidiary's assets, including bank accounts and properties, due to a court ruling related to a lawsuit. It details the affected accounts, the legal basis for the company's response, and the impact on operations. The document is an official announcement about a legal and financial situation affecting the company, but it does not contain financial statements, audit results, or detailed financial performance data. It is not a full report like an Annual Report or Interim Report, nor is it a certification or voting result. It is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about asset freezes and legal matters that do not fit other specific categories.
2015-11-02 Chinese
2015年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "江苏四环生物股份有限公司 2015 年第三季度报告全文" which translates to "Jiangsu Sihuan Biological Co., Ltd. 2015 Third Quarter Report Full Text." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2015. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2015
2015-10-28 Chinese
2015年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2015 Third Quarter Report" of 江苏四环生物股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as total assets, net profit, earnings per share, cash flow, and changes in shareholders, which are typical contents of an Interim / Quarterly Report. The document length is 7967 characters, which is sufficient to contain substantive financial data and analysis, not just an announcement or summary. There is no indication that this is an annual report, audit report, or earnings release. The presence of detailed financial tables and management discussion confirms it is a quarterly report rather than a brief earnings release or presentation. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2015
2015-10-28 Chinese
详式权益变动报告书（已取消）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "详式权益变动报告书" which translates to a "Detailed Equity Change Report". It is issued by an information disclosure obligor (中微小企业投资集团股份有限公司) regarding its increase in shareholding in 江苏四环生物股份有限公司, a listed company on the Shenzhen Stock Exchange. The document contains detailed information about the shareholding changes, the purpose of the equity change, the method of share acquisition, funding sources, future plans, impact analysis on the listed company, and financial data of the information disclosure obligor. It also references compliance with Chinese securities laws and specific disclosure standards related to equity changes and acquisitions. This type of document corresponds to a Major Shareholding Notification (MRQ), which reports changes in significant share ownership levels crossing thresholds. The document is comprehensive and not merely an announcement or a certification, and it is not an annual or interim report, nor a proxy or voting result announcement. Therefore, the correct classification is MRQ with high confidence.
2015-10-26 Chinese
关于公司股东详式权益变动报告书相关内容补充更正的公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement (430 characters) regarding a correction and supplementary disclosure related to a detailed equity change report by a major shareholder. It references a previously disclosed 'detailed equity change report' and provides additional financial information (cash flow statement) related to the shareholder's report. The document is an announcement about changes to a major shareholding notification, not the full report itself. Therefore, it fits the category of Major Shareholding Notification (MRQ).
2015-10-26 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.